COMPASS Pathways presents largest ever study of psilocybin therapy, at American Psychiatric Association annual meeting May 23, 2022
COMPASS Pathways plc announces first quarter 2022 financial results and business highlights May 10, 2022
COMP360 Psilocybin Therapy Shows Potential In Exploratory Open-Label Studies For Anorexia Nervosa And Severe… May 3, 2022
COMPASS Pathways And Partners Launch The Centre For Mental Health Research And Innovation, In The UK Mar 24, 2022
COMPASS Pathways announces financial results for the fourth quarter and full year 2021 and business highlights Feb 24, 2022
Two Thirds Of Physicians Surveyed Believe Psilocybin Therapy Has Potential Benefit For Patients With Treatment-Resistant… Jan 19, 2022
